Alright, let's get one thing straight: Pfizer's Q3 earnings are out, and everyone's wetting their pants over the fact that they "beat expectations." Give me a break. The Numbers Ga...
Nebius: Why the Stock is Falling
IRS: Quietly Expanding Tax Breaks for the Ultrawealthy
SpaceX: What's *Really* Going On, and the Corporate Spin
XRP's Price Leap: Decoding the Momentum and What It Signals for the Future of Finance
The Proposed $2,000 Tariff Check: Analyzing the Numbers and Economic Reality